Although the inhibitory effects of IFN-α and -β on prostate cancer are milder than those of IFN-γ28, these results suggested that ESS2-dependent type I IFN target genes may regulate prostate cancer progression. The gene discussed is ESS2; the disease is Familial prostate cancer.